Deborah Heart and Lung Center Department of Cardiology, Section of Nuclear Medicine, has been granted a three-year term of accreditation by the Intersocietal Accreditation Commission (IAC) in Nuclear Cardiology, demonstrating the hospital’s ongoing commitment to providing quality patient care in nuclear cardiology.

Early detection of life threatening heart disorders, stroke and other diseases is possible through the use of nuclear cardiology procedures performed at Deborah. Cardiovascular diseases are the leading cause of death in the United States. On average, one American dies every 39 seconds from disorders of the heart and blood vessels.

There are many factors that contribute to an accurate diagnosis based on nuclear cardiology. The training and experience of the technologist performing the examination, the type of equipment used and the quality assessment metrics each facility is required to measure, all contribute to a positive patient outcome. IAC accreditation is a “seal of approval” that patients can rely on as an indicator of consistent quality care and a dedication to continuous improvement.

Accreditation by the IAC indicates that Deborah’s Nuclear Medicine department has undergone an intensive application and review process and is found to be in compliance with the published standards, thus demonstrating a commitment to quality patient care in nuclear cardiology. Comprised of a detailed self-evaluation, followed by a thorough review by a panel of medical experts, the IAC accreditation process enables both the critical and operational and technical components of the Hospital to be assessed, including representative case studies and their corresponding final reports.

Deborah Heart and Lung Center in Browns Mills, NJ is an 89-bed teaching hospital that specializes in the prevention, diagnosis, research, and treatment of heart, lung, and vascular diseases. Founded in 1922, Deborah has been a regional and nationally recognized leader throughout its 100-year history, during which time it has healed 2.3 million patients from every corner of the United States and 87 countries in the world. From performing the first open heart surgeries (adult and pediatric) in New Jersey, to running one of the highest volume left-ventricular assist device (LVAD) implant programs in the region, Deborah has stood at the forefront of medical innovation, all while never wavering from its founding mission “there is no price on life.” Deborah is consistently recognized as a leader in patient care from the Centers for Medicare and Medicaid Services, ranked among the top hospitals in New Jersey for patient satisfaction; holds a top-tier Society of Thoracic Surgeons rating which places Deborah among the best cardiac surgery programs in the country; and is designated a national Top Teaching Hospital by The Leapfrog Group. Deborah is an Alliance member of the Cleveland Clinic Heart, Vascular & Thoracic Institute.